Microdosing vs SSRIs: What’s Happening in the Brain and Why It Matters
What We Explore in this Webinar:
What brain imaging (PET, fMRI) reveals about SSRIs vs microdosing
How psychedelics boost brain connectivity and neuroplasticity
Why Default Mode Network flexibility is key to emotional regulation
Microdosing’s potential to support depression, anxiety, and PTSD—especially when SSRIs fall short
The REBUS model: how psychedelics help unlock stuck mental patterns
Real-world implications for individuals and practitioners
Where research still needs to catch up—and how you can be part of the movement
Speakers & Hosts
Robin Carhart-Harris, PhD
Neuropharmacologist, Psychologist, and Ralph Metzner Distinguished Professor in Neurology and Psychiatry at the University of California, San Francisco.
Paul Austin
Co-Founder and Educational Director of Microdosing Collective, Founder of Third Wave and the Psychedelic Coaching Institute.
John Downs
Executive Director of Microdosing Collective
NEWSLETTER
Subscribe to THE DOSE and get the latest microdosing news, expert insights, legalization updates, and exclusive events—delivered straight to your inbox! 📩
Thank you! Check your email for confirmation.
Oops! Something went wrong while submitting the form.
